The Better Care Reconciliation Act of 2017 vs. The American Health Care Act: Summary of Key Differences

Jun 23, 2017

Reading Time : 1 min

By: G. Hunter Bates, Rachel Claire Kurzweil, Beth Collins (Consultant) & Maral Arslanian (Public Policy Specialist)

The Congressional Budget Office is expected to release its cost estimate for the BCRA early next week, with Senate Majority Leader Mitch McConnell (R-KY) aiming for a floor vote before the July 4 recess week. Early resistance from a handful of both moderate and conservative senators (including Sens. Ted Cruz (R-TX), Rand Paul (R-KY) and Dean Heller (R-NV)) threatens the BCRA’s passage, but negotiations are ongoing, and additional changes are expected before the bill comes up for a vote.

Like the AHCA, the BCRA would not repeal the ACA in its entirety—partially due to conscious policy decisions, but also because of procedural limits within Senate Budget Reconciliation rules. For instance, both the AHCA and the BCRA would maintain some of the “popular” insurance market reforms in Title I of the ACA, such as rules requiring issuers to offer dependent coverage until age 26, prohibitions on annual and lifetime limits, and prohibition of discrimination based on race, nationality, disability or gender. Further, neither bill proposes changes to any Medicare provisions from Title III of the ACA, such as those implementing quality- and value-based provider payment reforms (many of which are budget neutral), the Center for Medicare and Medicaid Innovation, and provider rate cuts (repeal of which would add to the deficit outside of the 10-year budget window in violation of procedural rules).

Click here to read the full summary of how changes in the BCRA compare to the AHCA.

Share This Insight

Previous Entries

Deal Diary

April 12, 2023

Read More

Deal Diary

2022-12-15

On December 14, 2022, the Securities and Exchange Commission (SEC) adopted amendments regarding Rule 10b5-1 insider trading plans and related disclosures. The amendments aim to strengthen investor protections concerning insider trading and to help shareholders understand when and how insiders are trading in securities for which they may at times have material nonpublic information (MNPI). In light of these amendments, issuers should review and revise, if needed, their insider trading policies and equity grant policies.

Read more.

...

Read More

© 2024 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.